Difficulty: Medium
Average Score: 92%
Practice
The following drugs may reduce the risk of recurrence or death post myocardial infarction EXCEPT:
Correct answer
C
Rationale
In this question from the Quizlet WVU Pharmacology Cardiovascular Drugs exam, the correct answer is C) Dexfenfluramine. This drug is not indicated for reducing the risk of recurrence or death post myocardial infarction.
A) Aspirin is a common drug used post-myocardial infarction to prevent clot formation and reduce the risk of another heart attack. B) Beta blockers are also commonly prescribed after a heart attack to reduce the workload on the heart and improve survival. D) Statins are prescribed to lower cholesterol levels, which can reduce the risk of further cardiovascular events.
Educationally, understanding the appropriate medications for post-myocardial infarction care is crucial for healthcare professionals. Aspirin, beta blockers, and statins are all evidence-based medications that have been shown to improve outcomes and reduce the risk of recurrence in patients who have experienced a heart attack. Dexfenfluramine, on the other hand, is not a standard treatment for this condition and does not provide the same benefits as the other options. This question reinforces the importance of knowing which medications are appropriate for specific conditions to provide optimal patient care.
A) Aspirin is a common drug used post-myocardial infarction to prevent clot formation and reduce the risk of another heart attack. B) Beta blockers are also commonly prescribed after a heart attack to reduce the workload on the heart and improve survival. D) Statins are prescribed to lower cholesterol levels, which can reduce the risk of further cardiovascular events.
Educationally, understanding the appropriate medications for post-myocardial infarction care is crucial for healthcare professionals. Aspirin, beta blockers, and statins are all evidence-based medications that have been shown to improve outcomes and reduce the risk of recurrence in patients who have experienced a heart attack. Dexfenfluramine, on the other hand, is not a standard treatment for this condition and does not provide the same benefits as the other options. This question reinforces the importance of knowing which medications are appropriate for specific conditions to provide optimal patient care.